Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Category: Pharma applications

June 29, 2022 Events / Non-pharma applications / Pharma applications

Special issue: Recent Insights in Chemistry and Technology of Cyclodextrins

International Journal of Molecular Sciences (MDPI) plans a Special Issue: Recent Insights in Chemistry and Technology of Cyclodextrins in connection

Continue reading

June 27, 2022 CD derivatives / Gene delivery / Supramolecular systems

Matthieu SOLLOGOUB at ICS 20

Matthieu Sollogoub, professor of Biological and Supramolecular Glycochemistry at Sorbonne University gave a plenary lecture at the 20th International Cyclodextrin

Continue reading

June 19, 2022 Drug delivery / Pharma applications

Carrier in carrier: Catanionic vesicles based on amphiphilic cyclodextrins complexed with DNA as nanocarriers of doxorubicin

The aim of this study was to evaluate the interaction between catanionic vesicles based on amphiphilic cyclodextrins (ModCBHD) and DNA–Doxorubicin

Continue reading

June 17, 2022 CD as API / Drug delivery / Pharma applications

CD-enabled, reactive oxygen species (ROS)-responsive size-reducible nanoassemblies for deeper atherosclerotic plaque penetration and enhanced macrophage-targeted drug delivery

Nanoparticle-based therapeutics represent potential strategies for treating atherosclerosis; however, the complex plaque microenvironment poses a barrier for nanoparticles to target

Continue reading

June 15, 2022 CD as API / Pharma applications / Uncategorized

Efficacy and safety of sugammadex for neuromuscular blockade reversal in pediatric patients: an updated meta-analysis of randomized controlled trials with trial sequential analysis

Background: A recent survey revealed that extensive off-label use of sugammadex in pediatric anesthesia deserved particular attention. The present study

Continue reading

June 14, 2022 Drug delivery / Pharma applications

In vitro-studies of adenosine- β-cyclodextrin inclusion complexes loaded into chitosan, sodium alginate and bentonite-based nanocomposite optimized by RSM as a sustained release system

The purpose of this study was to prepare an adenosine (ADS): β-CD inclusion complex that could be consistently incorporated into

Continue reading

June 10, 2022 Drug delivery / Pharma applications

Biophysical Studies and In Vitro Effects on Tumor Cell Lines of Cannabidiol and Its Cyclodextrin Inclusion Complexes

Phytocannabinoids possess anticancer properties, as established in vitro and in vivo. However, they are characterized by high lipophilicity. To improve

Continue reading

June 7, 2022 Drug delivery / Pharma applications

Electrospun Nanofibers for Drug Delivery Application

A recently published book titled “Applications of Polymer Nanofibers” (Wiley, 2022) contains a chapter on “Electrospun Nanofibers for Drug Delivery

Continue reading

June 2, 2022 CD derivatives / Gene delivery / Pharma applications

Tetraethylenepentamine-Coated β Cyclodextrin Nanoparticles for Dual DNA and siRNA Delivery

Tetraethylenepentamine-coated β-cyclodextrin (TEPA-BCD) nanoparticles were synthesized, characterized, and evaluated for targeted cell delivery of plasmid DNA and siRNA. The cationic

Continue reading

June 1, 2022 CD as API / Pharma applications

Brain uptake and distribution patterns of 2-hydroxypropyl-ß-cyclodextrin after intrathecal and intranasal administration

2-hydroxypropyl-ß-cyclodextrin (kleptose) is used for the treatment of Niemann–Pick disease. Kleptose crosses the blood–brain barrier poorly, in part because of

Continue reading

Posts navigation

1 2 3 … 64 Next Posts»

Recent Posts

  • Special issue: Recent Insights in Chemistry and Technology of Cyclodextrins
  • Special issue: Cyclodextrins as building blocks for new materials
  • Matthieu SOLLOGOUB at ICS 20
  • CicloTech®, a new platform to improve trans-ungual drug release
  • Prof. Kohzo Ito at ICS 20

Tags

antiviral Biotechnology Cancer therapy Captisol Cholesterol Clinical trial conference coronavirus Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems FDA Food Gilead History HPBCD Nanoparticles nanotechnology Niemann Pick Disease RAMEB remdesivir SBECD Special issue Sugammadex Synthesis Trappsol wastewater treatment

Follow Us

  • LinkedIn
  • Twitter
  • Facebook

Categories

  • Agriculture (13)
  • Analysis (27)
  • CD as API (177)
  • CD derivatives (229)
  • Cosmetics and toilettry (18)
  • Drug delivery (347)
  • E-ducation (49)
  • Environmental (62)
  • Events (149)
  • Food (100)
  • Gene delivery (8)
  • In Hungarian (4)
  • Life sciences (8)
  • Non-pharma applications (166)
  • Other industrial use (51)
  • Pharma applications (586)
  • Supramolecular systems (19)
  • Uncategorized (33)

Top Posts

  • Special issue: Recent Insights in Chemistry and Technology of Cyclodextrins
  • CicloTech®, a new platform to improve trans-ungual drug release
  • How air fresheners work?
  • Matthieu SOLLOGOUB at ICS 20
  • Special issue: Cyclodextrins as building blocks for new materials
  • Use of cyclodextrins as agrochemical delivery system
  • Practical Considerations about the Cyclodextrin Solubilities – A Quickstart Guide for Newbies
  • "NON-PHARMA USES OF CYCLODEXTRINS: Food; Nutraceuticals, Environmental and Other Industries, Agriculture” (webinar)
  • ICS2020 in Sicily concluded
  • Prof. Kohzo Ito at ICS 20

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 450 other subscribers

 

Loading Comments...